A new drug developed at Lancaster University that may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials.
One of the world’s leading innovation thinkers has worked with Lancashire businesses and North West health professionals during a visit to Lancaster University.
A clinical trial into the effects of a diabetes drug could change the way Alzheimer’s disease is treated.
Health and medicine students at Lancaster University have visited a manufacturing site of one of the world’s leading pharmaceutical companies.
Science and art are often thought to be polar opposites – so why did a group of artists attend lab sessions in the Faculty of Health and Medicine?
This one day conference was hosted by CETAD in the Faculty of Health and Medicine with support from Health Education North-West. The event attracted 30 practitioners working in organisational development (OD) roles in health and social care organisations in the North-West.
The first study to examine the use of cannabis in the context of daily life among people with Bipolar Disorder has shown how the drug is linked to increases in both manic and depressive symptoms.
The development of Inflammatory Bowel Disease (IBD) may be influenced through a protein in the gut leading to inflammation according to research.
Many LGBTQ young people who self-harm or consider suicide are in difficult circumstances because of hostility to their sexual orientation or gender identity, say researchers.
The Biomedical and Life Sciences (BLS) Division is opening its doors to artists who want to explore the theory and practice of microbiological processes.